8-K
Current Report
CNS Pharmaceuticals, Inc. Filed Acc 0001683168-25-001174
Shareholder rights changed · Other events
- Item 3.03 Material modification to rights of security holders
- Item 8.01 Other events
From the SEC's structured data for this filing
Loading cns_8k.htm…